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The KDIGO acute kidney injury guidelines
for cardiac surgery patients in critical care:
a validation study
Samuel H. Howitt1,2* , Stuart W. Grant1, Camila Caiado3, Eric Carlson4, Dowan Kwon1, Ioannis Dimarakis5,
Ignacio Malagon1,2 and Charles McCollum1
Abstract
Background: The Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury (AKI) guidelines assign
the same stage of AKI to patients whether they fulfil urine output criteria, serum creatinine criteria or both criteria
for that stage. This study explores the validity of the KDIGO guidelines as a tool to stratify the risk of adverse
outcomes in cardiac surgery patients.
Methods: Prospective data from consecutive adult patients admitted to the cardiac intensive care unit (CICU)
following cardiac surgery between January 2013 and May 2015 were analysed. Patients were assigned to groups
based on the criteria they met for each stage of AKI according to the KDIGO guidelines. Short and mid-term
outcomes were compared between these groups.
Results: A total of 2267 patients were included with 772 meeting criteria for AKI-1 and 222 meeting criteria for AKI-
2. After multivariable adjustment, patients meeting both urine output and creatinine criteria for AKI-1 were more
likely to experience prolonged CICU stay (OR 4.9, 95%CI 3.3–7.4, p < 0.01) and more likely to require renal
replacement therapy (OR 10.5, 95%CI 5.5–21.9, p < 0.01) than those meeting only the AKI-1 urine output criterion.
Patients meeting both urine output and creatinine criteria for AKI-1 were at an increased risk of mid-term mortality
compared to those diagnosed with AKI-1 by urine output alone (HR 2.8, 95%CI 1.6–4.8, p < 0.01). Patients meeting
both urine output and creatinine criteria for AKI-2 were more likely to experience prolonged CICU stay (OR 16.0,
95%CI 3.2–292.0, p < 0.01) or require RRT (OR 11.0, 95%CI 4.2–30.9, p < 0.01) than those meeting only the urine
output criterion. Patients meeting both urine output and creatinine criteria for AKI-2 were at a significantly
increased risk of mid-term mortality compared to those diagnosed with AKI-2 by urine output alone (HR 3.6, 95%CI
1.4–9.3, p < 0.01).
Conclusions: Patients diagnosed with the same stage of AKI by different KDIGO criteria following cardiac surgery
have significantly different short and mid-term outcomes. The KDIGO criteria need to be revisited before they can
be used to stratify reliably the severity of AKI in cardiac surgery patients. The utility of the criteria also needs to be
explored in other settings.
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Background
Acute Kidney Injury (AKI) occurs in up to 50% of pa-
tients following cardiac surgery [1, 2]. Even in its mildest
form, AKI is associated with increased mortality and
prolonged Critical Care Unit stay [3–6]. AKI requiring
renal replacement therapy (RRT) occurs in 2–5% of pa-
tients following cardiac surgery and is associated with
mortality of up to 60% [1, 7, 8]. The Kidney Disease: Im-
proving Global Outcomes (KDIGO) AKI guidelines were
designed to standardise the criteria for AKI based on serum
creatinine and urine output (Table 1) [9]. Patients are
assigned the same stage of AKI regardless of which criteria
(urine output, serum creatinine or both) for that stage are
met. However, concerns have been raised that the guide-
lines’ urine output criteria are poorly calibrated [10].
Studies validating the KDIGO guidelines following car-
diac surgery have frequently stratified patient risk based
on serum creatinine alone as reliable urine output data
are difficult to collect [1, 11–13]. Studies that have had
access to urine output data have tended to be relatively
small and have disagreed on the importance of urine
output when identifying those at risk of adverse out-
comes. [2, 14, 15]. A recent study with access to urine
output data after cardiac surgery did demonstrate that
patients with AKI diagnosed on oliguria alone had in-
creased long-term mortality but due to the relatively
small sample size they were unable to assess the import-
ance of urine output within each AKI level [6].
The objective of this study was to validate the KDIGO
guidelines for AKI by assessing the outcomes of patients
meeting different criteria for each stage of AKI after car-
diac surgery.
Methods
Data
Data from consecutive patients admitted to the cardiac in-
tensive care unit (CICU) following cardiac surgery at
Wythenshawe Hospital (part of Manchester University
NHS Foundation trust) were collected prospectively
between January 2013 and May 2015. Wythenshawe Hos-
pital is a tertiary centre for adult cardiac surgery, cardio-
thoracic transplantation and mechanical circulatory
support as a bridge to cardiac transplantation or recovery.
Patients requiring RRT preoperatively and those with no
preoperative creatinine values were excluded as shown in
Fig. 1. Patients who received mechanical circulatory sup-
port were excluded from length of stay (LOS) analyses as
their CICU stay was prolonged while awaiting definitive
treatment. All data were collected as part of the Vascular
Governance North West (VGNW) database and processed
according this project’s protocols and ethical approvals.
Serum creatinine concentration was usually measured
daily and all available results were extracted from the hos-
pital’s pathology laboratory database. Our institution’s la-
boratory measures creatinine using techniques based on
Jaffe chemistry with a total imprecision of < 6%. Every cre-
atinine value for each patient was analysed and both relative
and absolute increases in creatinine were used to classify
AKI stages according to the KDIGO criteria (Table 1). The
relative increases were calculated using the most recently
recorded preoperative level as the baseline value. Urine out-
put was recorded hourly on the CICU electronic patient
record. Where the hourly value was recorded as none or
zero, this value was accepted whereas when no value was
entered for a given hour the next volume of urine recorded
was divided equally by the number of blank hours prior to
this recording. Whenever urine output fell below the
thresholds in the KDIGO criteria, the time and appropriate
stage of AKI was recorded. The need for RRT and postop-
erative LOS on CICU were identified from the electronic
patient record. Serum creatinine concentration and urine
output measurements recorded after initiation of RRT were
not included in analyses as both are influenced heavily by
RRT itself.
The hospital clinical governance database recorded
2-year all-cause mortality and the preoperative comor-
bidity, urgency and complexity of surgery as measured
by the logistic EuroSCORE [16]. Prolonged LOS was de-
fined as a CICU stay longer than 120 h for cardiac trans-
plant patients or > 72 h for all other patients.
Statistical analyses
Patients were assigned to groups based on the stages of
AKI they reached according to the KDIGO guidelines.
Within the groups that reached each AKI stage, patients
were categorised as either i) meeting the urine output
criteria ii) meeting the serum creatinine criteria or iii)
meeting both urine output and serum creatinine criteria.
Rates of prolonged LOS, RRT and 2-year mortality for
those who did not develop AKI were compared with
those for patients diagnosed with AKI-1 by urine output
alone. Analyses within groups of patients meeting differ-
ent combinations of criteria for each stage of AKI were
Table 1 KDIGO criteria for diagnosis of AKI in adults [9]
Stage of AKI Serum Creatinine Urine output
1 1.5–1.9 times baseline
OR
≥0.3 mg/dl (≥26.5 μmol/l)
increase within 48 h
< 0.5 ml/kg/h for 6–12 h
2 2.0–2.9 times baseline < 0.5 ml/kg/h for ≥12 h
3 ≥3.0 times baseline
OR
Increase in serum creatinine
to ≥4.0 mg/dl (≥353.6 μmol/l)
OR
Initiation of renal replacement
therapy
< 0.3 ml/kg/h for ≥24 h
OR
Anuria for ≥12 h
Each stage of AKI is diagnosed when any of the criteria for that stage of AKI
are met
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then performed. The null hypothesis was that outcomes
would be similar between patients diagnosed with the
same stage of AKI based on the different KDIGO
criteria.
Univariable analyses of categorical outcomes were per-
formed using the chi-square test or Fisher’s exact test in
the event of sparse data. The logistic EuroSCORE [16]
which calculates mortality risk for cardiac surgery based
on 13 preoperative variables (including preoperative
renal function) and four operative variables was used to
adjust for surgical risk in multivariable logistic regres-
sion models. The logistic EuroSCORE has been shown
to have adequate discriminatory ability in UK cardiac
surgery [17]. The results of the multivariable analyses
are detailed in the Additional file 1.
Univariable and multivariable analyses of mid-term
mortality rates were performed using the log-rank test
and Cox proportional hazards regression modelling
respectively. Data cleaning and statistical analyses
were conducted using R (R Foundation for statistical
computing) [18].
Results
Data from 2284 patients were available. Seven patients
who required RRT preoperatively and ten patients with
no preoperative creatinine values were excluded leav-
ing 2267 patients for the analysis (Fig. 1). Patient
characteristics are shown in Table 2. There were 1448
patients who did not develop AKI during their CICU
stay. A total of 819 (36.1%) developed AKI and 147
(6.5%) required RRT. There were 177 (7.8%) patients
who died within two years of surgery. Of the 1448
patients who did not develop AKI, 255 (17.7%) had a
prolonged LOS on CICU and the 2-year mortality
rate for this group was 3.9%.
Acute kidney injury stage 1 (urine output only) vs no AKI
AKI-1 was diagnosed in 772 (34.1%) patients (Table 3)
with 370 (47.9%) of these patients meeting only the
urine output criterion (AKI-1-UO). As AKI-1-UO pa-
tients had the best outcomes (among patients who de-
veloped AKI) these patients were compared with the no
AKI group. On univariable analysis, the rate of pro-
longed LOS for AKI-1-UO (39.6%) was significantly
higher than for patients without AKI (p < 0.01). There
were 22 (5.9%) AKI-1-UO patients who died within
2-years although this was not statistically significantly
higher than the 2-year mortality rate in the no AKI
group (p = 0.10). On multivariable analysis adjusted for
the logistic EuroSCORE the risk of prolonged LOS for
AKI-1-UO was higher (OR 2.8, 95%CI 2.2–3.6, p < 0.01)
but the mortality risk within the first two years was not
significantly higher (HR 1.4, 95%CI 0.9–2.3, p = 0.18)
than for those without AKI.
Acute kidney injury stage 1
Of the other patients diagnosed with AKI-1, 192 (24.9%)
met only the serum creatinine concentration criteria
(AKI-1-sCr) and 210 (27.2%) met both urine output and
creatinine criteria (AKI-1-both). Details of the outcomes
for these groups are shown in Table 3. On univariable
analysis, rates of prolonged LOS and RRT were signifi-
cantly higher for AKI-1-sCr than for AKI-1-UO patients
(p < 0.01 for both). The 2-year mortality rate for
AKI-1-sCr was also significantly worse than that for
AKI-1-UO (p < 0.01). Outcomes for those with
AKI-1-both were worse still with prolonged LOS and
RRT rates significantly worse than those for the
AKI-1-sCr group (p < 0.02 for both). The 2-year mortal-
ity rate for AKI-1-both was higher than that for
AKI-1-sCr, but this difference did not achieve statistical
significance (p = 0.09). The 2-year mortality rate for
Fig. 1 Flow chart for inclusion of patients in analyses. RRT = renal replacement therapy, sCR = serum creatinine result, MCS =mechanical
circulatory support, PLOS = prolonged length of stay
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AKI-1-both was however significantly higher than that
for AKI-1-UO (p < 0.01).
On multivariable analysis adjusted for the logistic
EuroSCORE, when compared with AKI-1-UO, those
with AKI-1-sCr had higher risks of prolonged LOS (OR
2.6, 95%CI 1.7–3.9, p < 0.01) and RRT (OR 3.2, 95%CI
1.5–7.2, p < 0.01). Similarly, compared with AKI-1-UO,
AKI-1-both was associated with even greater risks of
prolonged LOS (OR 4.9, 95% CI 3.3–7.4, p < 0.01) and
RRT (OR 10.5, 95%CI 5.5–21.9, p < 0.01). Mortality risk
within the first two years following surgery was greater
for AKI-1-both than that for AKI-1-UO (HR 2.8, 95% CI
1.6–4.8, p < 0.01) but the smaller difference in mortality
risk between AKI-1-sCr and AKI-1-UO over the same
period (HR 1.4, 95%CI 0.7–2.7) was not statistically sig-
nificant (p = 0.29).
Acute kidney injury stage 2
There were 222 (28.8%) patients with AKI-1 who pro-
gressed to AKI-2. In 97 (43.7%) of these patients, AKI-2
was based on urine output alone (AKI-2-UO), in 92
(41.4%) it was based on serum creatinine concentration
alone (AKI-2-sCr) and in 33 (14.7%) diagnosis was based
on both criteria (AKI-2-both). Outcomes for these
groups are shown in Table 4. On univariable analysis,
the rates of prolonged LOS and RRT for AKI-2-sCr were
significantly higher than for AKI-2-UO (p ≤ 0.01 for
both) but the difference in 2-year mortality was not sta-
tistically significant (p = 0.20). Again, the rates of pro-
longed LOS and RRT for AKI-2-both were significantly
higher than for AKI-2-sCr (p ≤ 0.02 for both) but the dif-
ference in 2-year mortality rates was not significantly
different (p = 0.16). 2-year mortality in the AKI-2-both
Table 2 Characteristics of patients admitted to the cardiac intensive care unit following cardiac surgery
Characteristic All (n = 2267) AKI-1UO
(n = 370)
AKI-1 sCr
(n = 192)
AKI-1 Both
(n = 210)
AKI-2 UO
(n = 97)
AKI-2 sCr
(n = 92)
AKI-2 Both
(n = 33)
Age, mean (sd), years 65.9 (11.6) 67.3 (10.5) 67.6 (12.7) 68.5 (11.8) 67.7 (10.9) 66.7(12.3) 64.4 (12.3)
Female gender, % 27.2 30.8 28.1 26.7 34.0 27.2 24.2
Weight, mean (sd), Kg 81.5 (15.8) 89.4 (16.6) 75.3 (14.0) 87.2 (17.7) 96.5 (17.3) 80.1 (16.3) 89.1 (18.0)
Logistic EuroSCORE, median
(Interquartile range)
4.0 (2.1–7.7) 4.4 (2.5–7.7) 7.7 (3.5–18.1) 6.3 (2.8–13.0) 4.3 (2.5–7.6) 9.7 (4.2–18.4) 5.6 (2.3–15.6)
Operation, n (%)
CABG 1211 (53.4) 177 (47.8) 56 (29.2) 92 (43.8) 49 (50.5) 28 (30.4) 10 (30.3)
Valve 477 (21.0) 93 (25.1) 50 (26.0) 39 (18.6) 26 (26.8) 23 (25.0) 8 (24.2)
CABG and Valve 301 (13.3) 60 (16.2) 41 (21.4) 39 (18.6) 13 (13.4) 12 (13.0) 5 (15.2)
Aortic 122 (5.4) 19 (5.1) 16 (8.3) 16 (7.6) 4 (4.3) 11 (12.0) 3 (9.1)
Cardiac Transplantation 53 (2.3) 5 (1.4) 19 (9.9) 10 (4.8) 1 (1.0) 8 (8.7) 4 (12.1)
MCS 39 (1.7) 6 (1.6) 8 (4.2) 6 (2.9) 2 (2.1) 4 (4.3) 2 (6.1)
Other – minor 20 (0.9) 3 (0.8) 1 (0.5) 5 (2.4) 0 (0.0) 3 (3.3) 1 (3.0)
Other – major 44 (1.9) 7 (1.9) 1 (0.5) 3 (1.4) 2 (2.1) 3 (3.3) 0 (0)
Urgency, n (%)
Elective 1321(58.3) 217 (58.6) 99 (51.6) 110 (52.4) 56 (57.7) 42 (45.7) 14 (42.4)
Urgent 890 (39.3) 145 (39.2) 83 (43.2) 89 (42.4) 38 (39.2) 43 (46.7) 17 (51.5)
Emergency 40 (1.8) 7 (1.9) 8 (4.2) 7 (3.3) 3 (3.1) 5 (5.4) 1 (3.1)
Salvage 16 (0.7) 1 (0.3) 2 1.0) 4 (1.9) 0 (0.0) 2 (2.2) 1 (3.1)
CPB time, median (Interquartile range),
minutes
101.0
(80.0–130.0)
100.0
(81.0–133.2)
129.0
(97.0–182.0)
107.5
(83.3–132.8)
99.0
(75.5–120.0)
112.0
(90.0–155.0)
123.0
(81.0–157.0)
UO urine output, sCr serum creatinine, CABG coronary artery bypass graft, MCS mechanical circulatory support, CPB cardiopulmonary bypass
Table 3 Influence of urine output and serum creatinine criteria for AKI-1 on outcomes
Criteria met N (%) Progressed to RRT, N(%) Prolonged LOS N(%) 2-year mortality, N(%)
Urine output alone 370 (47.9) 16 (4.3) 145 (39.6) 22 (5.9)
Creatinine alone 192 (24.9) 28 (14.6) * 119 (64.7)* 24 (12.5)*
Urine output AND Creatinine 210 (27.2) 58 (27.6) *† 155 (76.0)* † 39 (18.6)*
AKI acute kidney injury, RRT renal replacement therapy, LOS length of stay
*= p values for comparison with urine output alone group < 0.01 on univariable analysis
† = p values for comparison with serum creatinine alone group < 0.02 on univariable analysis
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group was however significantly higher than that in
the AKI-2-UO group (p = 0.01).
On multivariable analysis, compared with AKI-2-UO,
AKI-2-sCr was associated with increased risks of pro-
longed LOS (OR, 2.1 95%CI 1.0–4.4, p = 0.04) and
RRT (3.2, 95%CI 1.4–7.7, p < 0.01). Similarly com-
pared with AKI-2-UO, AKI-2-both carried even
greater risk of prolonged LOS (OR 16.0, 95% CI 3.2–
292.0, p < 0.01) and RRT (OR 11.0, 95%CI 4.2–30.9, p
< 0.01). Mortality during the first two postoperative
years was significantly higher for AKI-2-both than
AKI-2-UO (HR 3.6, 95% CI 1.4–9.3, p < 0.01) but the
difference in mortality risk between AKI-2-sCr and
AKI-2-UO was not statistically significant (HR 1.5,
95%CI 0.6–3.5, p = 0.40).
Acute kidney injury stage 3
AKI-3 by KDIGO criteria was diagnosed in 173 patients.
In 47 (27.2%) of these patients, criteria for AKI-1 or
AKI-2 had not been met before RRT was started almost
immediately after surgery. There were 26 (15.0%) pa-
tients who met AKI-3 criteria based on urine output or
creatinine without needing renal replacement therapy.
In 16 of these patients, AKI-3 was based on a high
serum creatinine levels with preserved urine output.
For nine AKI-3 patients, anuria was observed for
12 h but only because the patient was not catheter-
ised prior to discharge to the ward. 157 (85%) pa-
tients diagnosed with AKI-3 suffered a prolonged
LOS. The small numbers within the subgroups pre-
cluded further analyses for AKI-3.
Comparative survival analysis
To allow a visual comparison of survival between AKI
stages rather than simply within AKI stages, patients
were grouped according to the urine output and serum
creatinine criteria met for the maximum stage of AKI
attained by the patient (up to and including AKI-2). The
group of patients who went straight to AKI-3 due to
early initiation of RRT is also shown. The survival curves
for these groups are shown in Fig. 2 which demonstrates
clear overlap of the 2-year mortality risk for AKI-1 and
AKI-2 patient subgroups.
Discussion
This represents the first study to explore the associations
between different criteria for multiple stages of
KDIGO-defined AKI and morbidity and mortality after
cardiac surgery. The frequency of AKI in our population
was broadly similar to that previously reported in car-
diac surgery patients [1, 19, 20]. RRT was more frequent
than reported elsewhere [1, 6–8, 14] possibly as a sub-
stantial number of high risk tertiary referral, transplant
and mechanical circulatory support patients are referred
to our centre.
Univariable analyses identified stepwise increases in
the risk of prolonged LOS, RRT and 2-year mortality
within each stage of AKI where patients met urine out-
put criteria, creatinine criteria or both. The increases in
risk of poor outcomes were confirmed on multivariable
analysis. This trend was previously reported in general
ICU patients [21] and in cardiac surgery patients [6] al-
though in the latter study the differences were not statis-
tically significant.
In this study, when comparing outcomes for patients
diagnosed with the same stage of AKI, all patients who
met any criteria for that stage were included. This ap-
proach was chosen to improve the clinical relevance of
our findings. In practice, clinicians cannot know whether
a patient with AKI-1 will subsequently develop AKI-2
until the higher stage is diagnosed or the patient has left
CICU without meeting AKI-2 criteria. As a consequence
of this approach, some patients appear in both the
AKI-1 and AKI-2 analyses. However, for comparison
of survival outcomes between patients suffering differ-
ent stages of AKI, each patient was placed retrospect-
ively into a subgroup according to the maximum AKI
stage reached during their CICU stay to avoid double
counting.
The KDIGO AKI guidelines were developed using ex-
pert opinion at a conference of the Kidney Disease: Im-
proving Global Outcomes group [9]. The guidelines
drew on previous diagnostic criteria such as AKIN [22]
and RIFLE [23] using urine output and creatinine to
grade severity of renal dysfunction. The guidelines refer-
enced several studies which demonstrated that patients
with increasing stages of AKI had greater subsequent
need for RRT and increased mortality risk. These find-
ings were used to support the stratification of AKI
Table 4 Influence of urine output and serum creatinine criteria for AKI-2 on outcomes
Criteria met N (%) Progressed to RRT, N(%) Prolonged ICU LOS, N(%) 2-year mortality, N(%)
Urine output alone 97 (43.7) 11 (11.3) 58 (61.1) 10 (10.3)
Creatinine alone 92 (41.4) 30 (32.6) * 70 (79.5)* 15 (16.3)
Urine output AND Creatinine 33 (14.9) 20 (60.6) *† 30 (97.0)* † 9 (27.3)*
AKI acute kidney injury, RRT renal replacement therapy, LOS length of stay
*= p values for comparison with urine output alone group ≤0.01 on univariable analysis
† = p values for comparison with serum creatinine alone group ≤0.02 on univariable analysis
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within the KDIGO guidelines. However, none of the val-
idation studies cited assessed the risk associated with
AKI diagnosed by hourly urine output measurement
[24–30]. The authors acknowledged that the urine out-
put thresholds were less well substantiated than those
related to serum creatinine concentration. Indeed, they
noted that “the influence of urinary output criteria on
AKI staging needs to be further investigated” and these
concerns have been echoed in subsequent work validat-
ing the guidelines in their entirety [10]. The calibration
of urine output thresholds might be particularly poor for
cohorts such as those who have undergone major sur-
gery for whom oliguria may be an appropriate response
to surgery.
Many studies assessing the KDIGO guidelines in car-
diac surgery patients used creatinine criteria alone to
classify AKI and explore its association with subsequent
adverse outcomes [12, 20]. Those which have included
urine output disagreed on whether UO diagnosed by
AKI was associated with adverse outcomes [2, 6, 14].
The current study contains more than three times the
number of participants as the largest similar study into
this topic in cardiac surgery patients. It is also the first
to explore differences between with rates of adverse
outcomes in those who meet different criteria within the
same AKI stage for both AKI-1 and AKI-2.
Our findings support conclusions drawn from earlier
studies that the risk of adverse outcomes associated with
AKI diagnosed by UO alone is relatively low [2, 14]. In
many cases the oliguria which resulted in diagnoses of
AKI-1 and AKI-2 by urine output alone was almost cer-
tainly an appropriate physiological response to the stress
of surgery. It is understandable that physiologically ap-
propriate oliguria was associated with a prolonged LOS
on CICU, but equally it is unsurprising that such oliguria
was not associated with significantly increased 2-year
mortality rates. In contrast, the risk of adverse outcomes
in patients who met both urine output and creatinine
criteria for AKI-1 or AKI-2 was markedly higher. Pa-
tients who suffered AKI-1 meeting both criteria had
worse 2-year survival than those who suffered AKI-2 by
urine output alone. This is highly relevant to treating cli-
nicians; in these instances an AKI-1 diagnosis may be
falsely reassuring. To ensure that the direct relationship
between increasing AKI stages and risk of adverse out-
comes is maintained, the AKI classification criteria may
need to be adjusted to reduce the importance placed on
isolated oliguria and increase the risk attributed to
Fig. 2 Kaplan Meier plots stratified according to the KDIGO criteria met for the maximum stage of AKI attained up to AKI-2. A separate group of
patients who went straight to AKI-3 is shown for comparison. AKI – Acute Kidney Injury, UO – urine output, sCr – serum creatinine
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fulfilling both urine output and creatinine criteria. While
we have studied patients undergoing cardiac surgery, simi-
lar findings may be reproduced in other cohorts, particu-
larly those undergoing other types of major surgery and
this should be the focus of further investigation.
Study limitations
This study is based on consecutive data from a large ter-
tiary cardiac surgery centre in the UK. The data utilised
has been rigorously cleaned using reproducible algo-
rithms. There were very few missing data and very few
cases excluded from the analysis. Postoperative urine
output and serum creatinine concentration data were
available for every patient. Creatinine was measured on
the first postoperative day for 2265 of the 2267 patients
(99.7%) and while this proportion did decline gradually
as the length of admission increased, even on the sev-
enth postoperative day, 220 of the 240 (91.7%) patients
who remained on CICU had a daily creatinine measure-
ment. Urine output data was available for all patients
throughout their admission.
Survival data was extracted from our hospital’s clinical
governance database which is populated automatically
by data from the NHS digital spine database. This ap-
proach is potentially less robust than using a dedicated
follow-up process due to potential time delays in updat-
ing the status of the patient after death. However, as at
least three months elapsed between the end of the follow
up period for all patients and the extraction of survival
data, this is unlikely to have affected the results.
We are confident that we have controlled for most
relevant preoperative and intraoperative differences be-
tween the groups in our regression analyses by using the
well validated logistic EuroSCORE. Although most
known confounders including pre-operative renal func-
tion were included as variables in the logistic Euro-
SCORE, we cannot guarantee that all potential
preoperative confounders have been adjusted for. Differ-
ences in post-operative management can have profound
effects on urine output and serum creatinine. In
addition, variations in post-operative management could
influence the outcome measures utilised in this study.
Adjusting for variations in post-operative management
was beyond the scope of this study and is unlikely to
have influenced the results as at the time of the study
there were no institutional guidelines regarding manage-
ment of AKI which would have led to systematic differ-
ences in treatments between the patient groups.
This study aimed to test the KDIGO criteria across the
most heterogeneous sample possible. The cohort in-
cluded those undergoing cardiac transplantation and
those receiving mechanical circulatory support. Such pa-
tients are known to have greater risks of AKI, RRT and
other adverse outcomes than the general cardiac surgery
population. Patients from these higher risk groups made
up 46%(n = 21) of those who started RRT prior to any
urine output or creatinine criteria for AKI being met
and this may have contributed to the high mortality rate
associated in the “straight to AKI-3” group (Fig. 2).
Conclusions
The current KDIGO guidelines assign the same AKI
stage to patients with markedly different risks of adverse
outcomes after cardiac surgery. This study identified a
stepwise increase in the frequency of poor outcomes fol-
lowing cardiac surgery where urine output criteria, cre-
atinine criteria or both criteria for each AKI stage were
met. Moreover, 2-year mortality for some subgroups
within AKI-1 clearly overlapped that of some subgroups
within AKI-2. The KDIGO criteria need to be revisited
before they can be used to reliably stratify the severity of
AKI in cardiac surgery patients on the critical care unit.
The applicability of these criteria to other patient groups
within the critical care unit, particularly those in whom
oliguria may be an appropriate physiological response
also requires further evaluation.
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